Derbyshire Medicines Management and Clinical Policies
| Formulary | Last Updated |
|---|---|
| Cardiovascular System | February 2026 |
| Prescribing Guideline | Last Updated | Review Date |
|---|---|---|
| Anticoagulation (oral) guideline with warfarin | May 2026 | April 2029 |
| Atrial Fibrillation | January 2026 | September 2028 |
| DOAC Position Statement | August 2025 | July 2028 |
| Heart Failure | April 2026 | March 2029 |
| Hypertension (diagnosed with ABPM) | July 2026 | June 2029 |
| Hypotension, Orthostatic - Advisory guidance on the prescribing of midodrine | March 2023 | February 2026 |
| Lipid management for primary and secondary prevention of cardiovascular disease | May 2026 | April 2029 |
| Lipid modification - Familial Hypercholesterolaemia | November 2023 | October 2026 |
| Lipid modification - Non FH | May 2024 | April 2027 |
| Low Molecular Weight Heparin prescribing (Enoxaparin and Tinzaparin) | March 2024 | February 2027 |
Relevant resources:
